News

Newest uMotif product release delivers next-gen eCOA/ePRO
Press Release

Newest uMotif product release delivers next-gen eCOA/ePRO

Read More
ePRO/eCOA, the ever changing patient burden and decentralized clinical trials
Podcast

ePRO/eCOA, the ever changing patient burden and decentralized clinical trials

Read More
Steve Rosenberg joins Craig Lipset, Co-Chair DTRA to discuss his passion for patient engagement
Video

Steve Rosenberg joins Craig Lipset, Co-Chair DTRA to discuss his passion for patient engagement

Read More
uMotif – first new validated eCOA/ePRO innovation since paper instruments deployed on smartphones
Press Release

uMotif – first new validated eCOA/ePRO innovation since paper instruments deployed on smartphones

Read More
uMotif experts to discuss the eCOA/ePRO market – what’s working, what’s wrong, and what patients need now
Press Release

uMotif experts to discuss the eCOA/ePRO market – what’s working, what’s wrong, and what patients need now

Read More
uMotif expands leadership team to support growth in US and EU markets
Press Release

uMotif expands leadership team to support growth in US and EU markets

Read More
uMotif and ClinOne unify eCOA / ePRO and eConsent
Press Release

uMotif and ClinOne unify eCOA / ePRO and eConsent

Read More
$25.5m of new investment from Athyrium Capital Management fund
Press Release

$25.5m of new investment from Athyrium Capital Management fund

Read More
Achieving more meaningful patient engagement in rare disease trials
Blog

Achieving more meaningful patient engagement in rare disease trials

Read More